Skip to main content
Sign In
 


 

Cancer Biology Program Students


Year you started the UC Denver Cancer Biology Program:

2007

Why you chose the UC Denver Cancer Biology Program:  

When I was looking at different schools, I liked the diverse areas of research accessible in the cancer biology program at UC Denver.  I felt that I could explore my different interests during my rotations.  

What labs you rotated in:

Doug Graham, MD PhD

Lynn Heasley, PhD

Cheng-Jun Hu, PhD

What lab you joined and why:

Lynn Heasley’s lab because throughout my first year I came to acknowledge modified signaling as a common theme in cancer progression; and I was drawn to the lab’s use of both cellular and molecular techniques. 

Description of your project:

My project involves looking at signaling pathways in NSCLC, particularly the family of FGF tyrosine kinase receptors.

Publications:

Marek, L., K. E. Ware, et al. (2009). "Fibroblast growth factor (FGF) and FGF receptor-mediated autocrine signaling in non-small-cell lung cancer cells." Mol Pharmacol 75(1): 196-207.

Kono, S. A., M. E. Marshall, K. E. Ware, L. E. Heasley (2009). "The fibroblast growth factor receptor signaling pathway as a mediator of intrinsic resistance to EGFR-specific tyrosine kinase inhibitors in non-small cell lung cancer." Drug Resist Updat 12(4-5): 95-102.

Keating, A. K., G. K. Kim, A. E. Jones, A. M. Donson, K. Ware, et al. (2009). "Inhibition of Mer and Axl receptor tyrosine kinases in astrocytoma cells leads to increased apoptosis and improved chemosensitivity." Mol Cancer Ther 9(5): 1298-307.

Where you attended undergraduate and what your major / minor(s) were:

Louisiana State University

Major: Microbiology

Minor: Chemistry

What you did (if anything) between undergraduate and graduate school:

I worked as a research associate in a microbiology lab for half a year.

What you like to do outside of school:

Camping, snowboarding, good food and hanging out with my dog Riley.

What is your favorite thing about Colorado:

Seeing the mountains everyday.